For the quarter ended December 2023, Teva Pharmaceutical Industries Ltd. (TEVA) reported revenue of $4.46 billion, up 14.8% over the same period last year. EPS came in at $1.00, compared to $0.71 in the year-ago quarter.The reported revenue represents a surprise of +12.36% over the Zacks Consensus Estimate of $3.97 billion. With the consensus EPS estimate being $0.75, the EPS surprise was +33.33%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...